Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam in Post-Herpetic Neuralgia
NCT00160667Phase 2Completed
- Sponsor
- UCB
- Start
- Oct 2004
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of brivaracetam in postherpetic neuralgia (PHN), sponsored by UCB. Started Oct 2004; status: completed.
02
Drugs
brivaracetam
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00160667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160667.